Find summaries of these recalls at MedShadow website: FDA Recalls for Compounded GLP-1s Recalls for Generics: Aripiprazole (Abilify) Bevacizumab (Avastin), Lisdexamfetamine (Vyvanse), Chlorpromazine, Sulfamethoxazole (Bactrim), Dextroamphetamine (Dexedrine), Entecavir Find highlights of nationwide recalls for these generics at our website: Recent Drug Recalls: Aripiprazole, Bevacizumab, Cyclobenzaprine, Lisdexamfetamine, Chlorpromazine, Sulfamethoxazole, Dextroamphetamine, Entecavir New Safety Warning for Briviact (brivaracetam) tablets, oral solution, and injection for intravenous use Seizure and epilepsy drug Briviact (brivaracetam) has a new warning about the risk of severe skin reactions, including severe rash with blisters and peeling skin
It further reduced apoptosis and oxidative damages in both Al 2 O 3 NPs treated HBE cells and animal lung tissues
Among participants with a starting BMI of at least 35 who continued into an extension period, average weight loss reached 30.3% at 104 weeks
In a Phase 2 clinical trial published in the New England Journal of Medicine in 2023 (Jastreboff et al